Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 3, 2010, Pages 375-380

  Ehrlich, Rita ^a   Ciulla, Thomas A ^b   Moss, Adam M ^a   Harris, Alon ^a  

^a INDIANA UNIVERSITY   (United States)

^b METHODIST HOSPITAL   (United States)

Author keywords

Bevacizumab; Triamcinolone; Vein occlusion

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA EDEMA; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MALE; PROGNOSIS; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77949268295     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1211-6     Document Type: Article

References (33)

1. S Bearelly S Fekrat 2004 Controversy in the management of retinal venous occlusive disease Int Ophthalmol Clin 44 4 85 102 10.1097/00004397-200404440- 00008 15577566 (Pubitemid 39392080)
2. S Dithmar LL Hansen FG Holz 2003 Retinal vein occlusion Ophthalmologe 100 561 577 10.1007/s00347-003-0820-4 1:STN:280:DC%2BD3szpvFKktg%3D%3D 12938661 (Pubitemid 36898816)
3. JG Clarkson 1994 Central vein occlusion study: photographic protocol and early natural history Trans Am Ophthalmol Soc 92 203 213 1:STN:280: DyaK2M7ptlWmsA%3D%3D 7533959
4. J Rehak M Rehak 2008 Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities Curr Eye Res 33 111 131 10.1080/ 02713680701851902 18293182 (Pubitemid 351302200)
5. H Noma A Minamoto H Funatsu H Tsukamoto K Nakano H Yamashita HK Mishima 2006 Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 244 309 315 10.1007/s00417-004-1087-4 1:CAS:528: DC%2BD28Xitlenur4%3D 16133018
6. SR Boyd I Zachary U Chakravarthy GJ Allen GB Wisdom IA Cree JF Martin PG Hykin 2002 Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion Arch Ophthalmol 120 1644 1650 1:CAS:528:DC%2BD38Xpslers7k%3D 12470137
7. PA Campochiaro G Hafiz SM Shah QD Nguyen H Ying DV Do E Quinlan I Zimmer-Galler JA Haller SD Solomon JU Sung Y Hadi KA Janjua N Jawed DF Choy JR Arron 2008 Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 791 799 10.1038/mt.2008.10 1:CAS:528:DC%2BD1cXjslCnsLc%3D 18362932
8. C Kaur WS Foulds EA Ling 2008 Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management Prog Retin Eye Res 27 6 622 647 10.1016/j.preteyeres.2008.09.003 1:CAS:528:DC%2BD1cXhtlyiu73E 18940262
9. Tao Y, Hou J, Jiang YR, Li XX, Jonas JB (2009) Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Eye. Aug 21 doi: 10.1038/eye.2009.220
10. Wu WC, Cheng KC, Wu HJ (2009) Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion. Eye Feb 13. doi: 10.1038/eye.2008.429
11. Kondo M, Kondo N, Ito Y, Kachi S, Kikuchi M, Yasuma TR, Ota I, Miyake K, Terasaki H (2009) Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12 months and multiple regression analysis. Retina Aug 10. doi: 10.1097/IAE.0b013e3181aa8e20
12. NZ Gregori GH Rattan PJ Rosenfeld CA Puliafito W Feuer HW Flynn Jr AM Berrocal L Al-Attar S Dubovy WE Smiddy SG Schwartz WH Lee TG Murray 2009 Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion Retina 29 7 913 925 10.1097/IAE.0b013e3181aa8dfe 19584649
13. GE Fish 2008 Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis) Trans Am Ophthalmol Soc 106 276 300 19277242
14. NS Ekdawi SJ Bakri 2007 Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment alone Eye 21 1128 1130 10.1038/sj.eye.6702903 1:STN:280:DC%2BD2svms1Kgsw%3D%3D 17585312 (Pubitemid 47263774)
15. Branch Vein Occlusion Study Group 1984 Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmology 98 271 282
16. IU Scott MS Ip PC VanVeldhuisen NL Oden BA Blodi M Fisher CK Chan VH Gonzalez LJ Singerman M Tolentino SCORE Study Research Group 2009 A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6 Arch Ophthalmol 127 9 1115 1128 10.1001/archophthalmol.2009.233 19752420
17. V Russo A Barone E Conte F Prascina A Stella ND Noci 2009 Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion Retina 29 4 511 515 10.1097/IAE.0b013e318195ca65 19174717
18. M Karacorlu SA Karacorlu H Ozdemir F Senturk 2007 Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion Retina 27 8 1026 1030 10.1097/IAE.0b013e3180645905 18040239 (Pubitemid 350304002)
19. NZ Gregori PJ Rosenfeld CA Puliafito HW Flynn Jr JE Lee EC Mavrofrides WE Smiddy TG Murray AM Berrocal IU Scott G Gregori 2006 One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion Retina 26 8 889 895 10.1097/01.iae.0000237111.82357.30 17031288 (Pubitemid 44547441)
20. JB Jonas I Akkoyun B Kamppeter I Kreissig RF Degenring 2005 Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion Eur J Ophthalmol 15 6 751 758 1:STN:280:DC%2BD2MnksVKhug%3D%3D 16329061 (Pubitemid 43074702)
21. JB Jonas I Akkoyun B Kamppeter I Kreissig RF Degenring 2005 Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide Eye 19 1 65 71 10.1038/sj.eye.6701395 1:CAS:528:DC%2BD2MXovVWh 15105817 (Pubitemid 40192642)
22. DB Roth C Cukras R Radhakrishnan WJ Feuer DL Yarian SN Green HM Wheatley J Prenner 2008 Intravitreal triamcinolone acetonide injections in the treatment of retinal vein occlusions Ophthalmic Surg Lasers Imaging 39 6 446 454 10.3928/15428877-20081101-16 19065973
23. TH Williamson A O'Donnell 2005 Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion Am J Ophthalmol 139 5 860 866 10.1016/j.ajo.2005.01.001 1:CAS:528: DC%2BD2MXjslKnsLg%3D 15860292 (Pubitemid 40614773)
24. ZF Bashshur RN Ma'luf S Allam FA Jurdi RS Haddad BN Noureddin 2004 Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion Arch Ophthalmol 122 8 1137 1140 10.1001/archopht.122.8.1137 1:CAS:528:DC%2BD2cXnt1enu7Y%3D 15302653 (Pubitemid 39031128)
25. MS Ip IU Scott PC VanVeldhuisen NL Oden BA Blodi M Fisher LJ Singerman M Tolentino CK Chan VH Gonzalez SCORE Study Research Group 2009 A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5 Arch Ophthalmol. 127 9 1101 1114 10.1001/archophthalmol.2009.234 19752419
26. L Wang H Song 2009 Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion Acta Ophthalmol 87 3 285 289 10.1111/j.1755-3768.2008.01205.x 18507724
27. D Iturralde RF Spaide CB Meyerle JM Klancnik LA Yannuzzi YL Fisher J Sorenson JS Slakter KB Freund M Cooney HF Fine 2006 Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study Retina 26 3 279 284 10.1097/00006982-200603000-00005 16508427 (Pubitemid 44318180)
28. J Hsu RS Kaiser A Sivalingam P Abraham MS Fineman MA Samuel JF Vander CD Regillo AC Ho 2007 Intravitreal bevacizumab (avastin) in central retinal vein occlusion Retina 27 8 1013 1019 10.1097/IAE.0b013e318050ca7c 18040237 (Pubitemid 350304000)
29. MD Rabena DJ Pieramici AA Castellarin MA Nasir RL Avery 2007 Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion Retina 27 4 419 425 10.1097/IAE.0b013e318030e77e 17420692 (Pubitemid 46624280)
30. K Kriechbaum S Michels F Prager M Georgopoulos M Funk W Geitzenauer U Schmidt-Erfurth 2008 Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study Br J Ophthalmol 92 4 518 522 10.1136/bjo.2007.127282 1:STN:280:DC%2BD1c3htVektA%3D%3D 18211942
31. F Prager S Michels K Kriechbaum M Georgopoulos M Funk W Geitzenauer K Polak UM Schmidt-Erfurth 2009 Intravitreal bevacizumab (Avastin(R)) for macular edema secondary to retinal vein occlusion-twelve-month results of a prospective clinical trial Br J Ophthalmol 93 4 452 456 10.1136/bjo.2008.141085 1:STN:280:DC%2BD1M3jt1ejug%3D%3D 19074916
32. GB Jaissle M Leitritz F Gelisken F Ziemssen KU Bartz-Schmidt P Szurman 2009 One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 247 1 27 33 10.1007/s00417-008-0916-2 1:CAS:528:DC%2BD1cXhtl2qtLjL 18696094
33. NM Bressler AR Edwards AN Antoszyk RW Beck DJ Browning AP Ciardella RP Danis MJ Elman SM Friedman AR Glassman JG Gross HK Li TJ Murtha TW Stone Jennifer K. Sun, of the Diabetic Retinopathy Clinical Research Network 2008 Retinal thickness on stratus optical coherence Tomography™ in people with diabetes and minimal or no diabetic retinopathy Am J Ophthalmol 145 5 894 901 10.1016/j.ajo.2007.12.025 18294608